May 17, 2014 by Michael Douglass and Dave WilliamsonDream or Reality? Obamacare Tax RepealSenate Republicans are pushing for a repeal vote. Should medical device stock investors start celebrating?
May 17, 2014 by Michael Douglass and Dave WilliamsonThe Biggest E-Cigarette Investing MythE-cigarettes may not be as helpful as people think.
May 17, 2014 by Michael Douglass and Dave WilliamsonNew FDA E-Cigarette Rules: What You Need to KnowLooking for a quick (three minute) primer on the FDA's proposed e-cigarette regulations? We've got you covered.
May 16, 2014 by Michael Douglass and Dave WilliamsonFinding Silver Linings: Incyte's Mixed ResultsIncyte had some bad news in a pancreatic cancer trial -- was the drop overdone?
May 16, 2014 by Michael Douglass and Dave WilliamsonBetter Buy: Isis vs. AegerionWhich drug -- and which stock -- is better?
May 16, 2014 by Michael Douglass and Dave WilliamsonCan CVS Overcome the Drug Poised to "Break the Country?"After Express Scripts' fury at hepatitis C drugs, CVS is surprisingly sanguine. What happened?
May 16, 2014 by Michael Douglass and Dave WilliamsonDoes Kindred's Offer Make Sense for Gentiva Shareholders?Aside from the price pop, is this really good news?
May 15, 2014 by Michael Douglass and Dave WilliamsonUp 62%: A Stock-Friendly Hostile BidKindred's bid turns hostile, and Gentiva shareholders made a big gain.
May 15, 2014 by Michael Douglass and Dave WilliamsonUp 31%: Why Pernix Therapeutics Surprised InvestorsWhy this move up makes sense.
May 15, 2014 by Michael Douglass and Dave Williamson1 Surprising Stock Drop that Makes Perfect SenseEarnings yielded some interesting stock movement.
May 15, 2014 by Michael Douglass and Dave WilliamsonA 3 Minute Clinic on CVS EarningsCVS reported earnings. Here are the major takeaways.
May 15, 2014 by Michael Douglass and Dave WilliamsonDown 50%: Should You Buy Corcept?Mifepristone failed in depression, now on to breast cancer?
May 11, 2014 by Michael Douglass and Dave Williamson1 Insurance Stock Embarrassing Its CompetitorsThis company seems to be constantly winning.
May 10, 2014 by Michael Douglass and Dave WilliamsonThe Truth Behind the Obamacare "Death Spiral"WellPoint released great first quarter numbers -- but how does Obamacare fit into the equation moving forward?
May 7, 2014 by Michael Douglass and Dave WilliamsonDown 14%: Time to Buy Athenahealth?This stock has been on a rollercoaster ride, and was just attacked by David Einhorn. What's an investor to do?
May 2, 2014 by Michael Douglass and Dave WilliamsonNet Income Down 21%: This Dividend Stock Popped AnywayManagement remained confident about 2014, and it showed.
May 2, 2014 by Michael Douglass and Dave WilliamsonDown 62%: Is Endocyte a Bad News Buy?Could this sell-off be a little overdone?
May 2, 2014 by Michael Douglass and Dave WilliamsonKey Takeaways from Bristol-Myers Squibb's EarningsBristol's earnings were pretty mixed -- what are the key takeaways?
May 2, 2014 by Michael Douglass and Dave WilliamsonExpress Scripts Earnings: 3 Things You Need to KnowThe reported numbers were concerning, but these 3 things may matter even more.
May 1, 2014 by Michael Douglass and Dave WilliamsonCatamaran Up 13%: Here's WhyThe pharmacy benefits manager had a great day on the market. Let's dive in to why.
